April 21 – 24, 2018: ECCMID, Madrid, Spain

April 21 – 24, 2018: ECCMID, Madrid, Spain
February 14, 2018 Franziska Daabour

Meet our scientists for exchange.

Anatol Luther, Ph.D., Oral Presentation, April 21, 16.30 – 16.40 h
see session: Hall L / OS046: New drugs and tricks against MDR bacteria
#O0246: Outer membrane protein targeting antibiotics (OMPTAs): a novel class with potent activity against Gram-negative organisms including XDR and colistin-resistant isolates

Glenn Dale, Ph.D., Symposium, April 24, 10.00 – 10.30 h
see session: Hall I / SY189: Early antimicrobial drug development news
#S0919: The diversity of AMP mimetics

Paper Poster Presentations, April 23, 13.30 – 14.30 h
see Paper Poster Arena PS083: Membrane-active antibiotics and peptides: in vitro and in vivo activity:

#P1661: Murepavadin activity tested against contemporary (2016-2017) clinical isolates of extensively drug-resistant (XDR) pseudomonas aeruginosa

#P1662: Antimicrobial activity of murepavadin tested against clinical isolates of pseudomonas aeruginosa collected in Europe, the United States and China

#P1665: Outer membrane protein targeting antibiotics (OMPTAs): in vivo characterization of a novel class of compounds with respect to pharmacokinetics, efficacy and renal toxicity

#P1666: Outer membrane protein targeting antibiotics (OMPTAs): a novel class with potent in vitro and in vivo activity against E. coli-harbouring mcr-1 and/or mcr-3 genes

#P1667: Investigation of the in vitro time-kill kinetics and the rate of resistance development by spontaneous mutations and serial passage of murepavadin and standard-of-care antibiotics towards P. aeruginosa

#P1668: Outer membrane protein targeting antibiotics (OMPTAs): investigation of the in vitro time-kill kinetics and rate of resistance development by serial passage

Find our program activity details: http://www.eccmidlive.org/